Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Can seam inspection
Method of treating lung cancer
Method for isomerisation of hop alpha-acids using heterogeneous alkaline earth metal based catalysts
LED string with a capability to maintain a current path and LED unit thereof
Method and apparatus for charging a power pack of a portable electronic device
Lithographic apparatus and device manufacturing method
Method and system for processing dictated information
  Randomly Featured Patents
Manipulable tool mount
Acetamides derived from 2,3-dihydro-3-phenyl-2-benzofuranone
Use of collagenase to facilitate guide wire crossing in total arterial occlusions
Endocardial defibrillation lead with multi-lumen body and axially mounted distal electrode
Automotive cooling system using a non-pressurized reservoir bottle
Photoelectric converting apparatus to prevent the outflow of excess carriers
Method of compensating for correlation between multiple antennas
Composite laminated armor structure
Fullerene based proton conductive materials